Paul, I would say that there is something really weird. Take a look of a high volume today which is almost 8 x the 3 M average.
ericson.reis
Posts
-
-
High volume and no news? weird
-
Why is the communication is so bad?
-
Krypton,
Good attitude.
Why no revenue has not beem generated?
what is the strategy to acquired a Avigan distributor and the Covid test?
Regarding the FDA approval?
Why did company hire so many employees if has not generated revenue? -
looks like the acquisition has a headwind and probably the issue is the valuation of Aipharma and the price of Aditx stocks. In my opinion Adixt should gives up of it and put focus on to generate revenue of AditxScore.
what is the pharmacy company’s name that invested USD17MM?
The PR of this company is joke. -
No news is not a good sign.
-
The PR and senior management have lack of knowledge about financial market and strategy. They have not finished the fitst acquisition of Aipharma and have announced a new one. Do they have skills to handle both?
Take a look of Toldos and Appili: their dilution put the shares really down, value some cents.
On the other side Appili has never had
revenue.
Let’s see if ADTX has capability to generate revenue from the new acquisitions wich would help the price of shares. -
The company is acquiring 2 companys at the same time and this demands close attention. It seems that ADT is looking for revenue generation. the lack of informationis pushing its stocks down.
-
Nag, basically it is a way out for both sides. In my humble opinion Aditx should not acquire this company. If Aipharma makes money why does it need a bridge loan? I have doubt about its valuation. Aditx must preserve the cash and put focus on to generate revenue.
-
Thomas, what kind of split?
-
Cretan, the stock plan was approved to distribute stocks to some employees.
-
The acquisition agreement was postponed to 12/16, but it is not clear yet the total amount and number of shares that will be issued. It seems that Aipharma does not have cash. Who knows the valutation of it?
Let’s see the result and to pray that Amro knows what he is doing besides to devaluate the stocks. -
Now news or details about this offering or the acquisition. Company stills hiring more people which could be a good sign or madness.
-
The high volume and daily pre mkt shows that insiders are taking advantage. Really weird situation.
-
This company has a really bad PR. Nothing about the acquisition but news about new offerinh without any link. the senior mgm has been able to destroy networth. They are the state of the art.
-
Thomas, What did you hear?
-
Let’s see if the management gives up of this acquisition, preserving cash and keeping focus on AditxScore’s sales.
-
Marek, the investors became concern that Aditx will spend USD15MM( USD8,5MM bridge loan and the remaining it will the issue of stocks), but Favipiravir test failed, so valuation of this acquisition would be a compromise.I pray that Aditx’s lawyers have included a clause to give up or to discuss a new price. Boeing gave up the USD5bi acquisition of Embraer.
-
The world of this company is falling apart and the senior management has been granted again with more stocks without any cost. They should buy stocks using their own money to show that they believe in the future of this company. Who are the short sellers? the same subscribers that provided the last two round of funds. They received warrants with no cost, so they became short sellers, doing a hedge. Simple as that. The yesterday conference was a real fiasco.
Now, seens that ADTX does not have choice and will acquire Ipharma. I hope that I am totally wrong. Let’s see. -
Ethan @3PM
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX
ADTX